Form 4 holding
Director
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- Security class
- Options to Purchase Common Stock
- Shares / value
- 11,632
- Estimated value
- $14,772
- Report date
- 30 Jun 2025
- Price
- $1.27
- Ownership
- Direct
- Underlying class
- Common
- Underlying amount
- 11,632